Stratec (ETR:SBS) Given a €77.00 Price Target at Berenberg Bank

Stratec (ETR:SBSGet Rating) has been assigned a €77.00 ($81.91) price target by equities researchers at Berenberg Bank in a research note issued on Friday, Borsen Zeitung reports. Berenberg Bank’s price objective would indicate a potential downside of 1.79% from the stock’s current price.

Several other equities research analysts have also recently issued reports on SBS. Deutsche Bank Aktiengesellschaft set a €119.00 ($126.60) price objective on shares of Stratec in a research report on Wednesday, February 15th. Hauck Aufhäuser Investment Banking set a €97.00 ($103.19) price target on shares of Stratec in a research note on Wednesday, March 1st.

Stratec Trading Up 0.6 %

Shares of ETR:SBS opened at €78.40 ($83.40) on Friday. The stock has a 50 day moving average of €82.87 and a 200 day moving average of €83.02. The company has a current ratio of 3.48, a quick ratio of 1.65 and a debt-to-equity ratio of 38.79. The company has a market cap of $950.99 million, a PE ratio of 34.39, a price-to-earnings-growth ratio of 10.43 and a beta of 0.30. Stratec has a 12-month low of €72.70 ($77.34) and a 12-month high of €130.60 ($138.94).

About Stratec

(Get Rating)

Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It operates through three segments: Instrumentation, Diatron, and Smart Consumables. The Instrumentation segment designs and manufactures automated analyzer systems, including service parts and consumables for clinical diagnostics and biotechnology customers.

Further Reading

Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with's FREE daily email newsletter.